Related Experiment Video

Updated: Jan 25, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Downregulation of CYB5D2 is associated with breast cancer progression

Diane Ojo1,2,3, David Rodriguez1,2,3, Fengxiang Wei4

  • 1Department of Medicine, McMaster University, Hamilton, Canada.

Scientific Reports
|May 1, 2019
PubMed

Insights

The study identifies CYB5D2 as a tumor suppressor in breast cancer (BC). Reduced CYB5D2 expression correlates with poor survival and is linked to specific gene mutations, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer (BC) remains a leading cause of mortality globally.
  • Understanding novel tumor suppressors is crucial for developing targeted therapies.
  • CYB5D2's role in breast cancer pathogenesis is largely unexplored.

Purpose of the Study:

  • To investigate the function of CYB5D2 in breast cancer.
  • To determine the association of CYB5D2 expression with clinical outcomes and molecular alterations.
  • To evaluate CYB5D2 as a potential prognostic biomarker.

Main Methods:

  • Analysis of CYB5D2 expression in breast cancer cell lines and patient datasets (TCGA, Curtis, Metabric).
  • Functional studies including overexpression and knockdown of CYB5D2 in MCF7 cells.
  • Bioinformatic analysis of differentially expressed genes and pathway enrichment.
  • Correlation analysis with clinical data, overall survival, and gene mutations (PIK3CA, GATA3, TP53, etc.).

Main Results:

  • CYB5D2 expression is significantly reduced in tamoxifen-resistant breast cancer and primary tumors.
  • CYB5D2 overexpression induces apoptosis, while knockdown enhances proliferation.
  • Downregulation of CYB5D2 is associated with decreased overall survival and is linked to mutations in key cancer-related genes.
  • A 21-gene signature derived from CYB5D2 expression robustly predicts poor survival and BC mortality.

Conclusions:

  • CYB5D2 functions as a tumor suppressor in breast cancer.
  • Reduced CYB5D2 expression is a significant prognostic indicator for poor survival.
  • CYB5D2 represents a potential therapeutic target and a valuable biomarker for breast cancer management.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.9K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.1K